FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • May 1st, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 1st, 2024 Company Industry JurisdictionTHIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into effective as of April 1, 2024 (the “Amendment Effective Date”), by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and Andrew Perry, an individual (“Employee”). Employee and the Company may be individually referred to as a “Party” and collectively as the “Parties.”
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • May 1st, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 1st, 2024 Company Industry JurisdictionTHIS SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into effective as of April 1, 2024 (the “Amendment Effective Date”), by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and Terry Murdock, an individual (“Employee”). Employee and the Company may be individually referred to as a “Party” and collectively as the “Parties.”
THIRD AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • May 1st, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 1st, 2024 Company Industry JurisdictionTHIS THIRD AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into effective as of April 1, 2024 (the “Amendment Effective Date”), by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and Rajesh Malik, an individual (“Employee”). Employee and the Company may be individually referred to as a “Party” and collectively as the “Parties.”
FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • May 1st, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 1st, 2024 Company Industry JurisdictionTHIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into effective as of April 1, 2024 (the “Amendment Effective Date”), by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and Monica Thomas, an individual (“Employee”). Employee and the Company may be individually referred to as a “Party” and collectively as the “Parties.”